Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433846 · ClinicalTrials.gov registry record
Predictors of Sepsis in Ex-Preterm Infants
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 40
- Enrollment target
NCT03433846 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT03433846 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The aims of this study are to: * Assess whether ex-preterm infants have a persistently immature immune system, which may decrease their ability to respond to infections, when they reach term-corrected gestational age. * Examine whether clinical history, nutrition status, and microbiome composition are linked to the immune composition of term and ex-preterm infants and whether these variables can be used to predict the risk of developing sepsis or having an immunologic disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2022-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03433846
The ClinicalTrials.gov registry entry for NCT03433846 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03433846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03433846 about?
NCT03433846 is a clinical study titled "Predictors of Sepsis in Ex-Preterm Infants". The aims of this study are to: * Assess whether ex-preterm infants have a persistently immature immune system, which may decrease their ability to respond to infections, when they reach term-corrected gestational age. * Examine whether clinical history, nutrition status, and microbiome composition ...
What is the current status of trial NCT03433846?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2019-04-18. Estimated completion is 2022-05-01.
Who is sponsoring clinical trial NCT03433846?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.